PGI2 - Cost Analysis of Certolizumab Pegol Compared With Available Biologic Agents For Crohn’s Disease In Mexico And Brazil
| Autor: | Aguirre, A, Naranjo, M, Bierschwale, H, Treglia, M |
|---|---|
| Zdroj: | In Value in Health November 2015 18(7):A866-A866 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect